Tarsus Pharmaceuticals, Inc.
TARS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001819790
In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Tarsus Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 75 | 2 | 69 | −4 |
| Shares | 20.5M | 445.8K | 20.5M | +487.9K (+2.4%) |
| Value | $350.8M | $7.63M | $301.0M | −$42.1M (−12.3%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Tarsus Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jefferies Financial Group Inc. | 445,758 | $6.53M | 0.11% |
| Swiss National Bank | 41,833 | $613.3K | 0.00% |
| Citadel Advisors LLC | 20,967 | $307.4K | 0.00% |
| Alps Advisors Inc | 18,076 | $265.0K | 0.00% |
| State of Wisconsin Investment Board | 17,364 | $254.6K | 0.00% |
| Innovis Asset Management LLC | 12,981 | $190.3K | 0.09% |
| Janney Montgomery Scott LLC | 11,640 | $171.0K | 0.00% |
| Callan Capital, LLC | 11,600 | $170.1K | 0.02% |
| China Universal Asset Management Co., Ltd. | 271 | $3.97K | 0.00% |
| Daiwa Securities Group Inc. | 107 | $2.00K | 0.00% |
| IFP Advisors, Inc | 30 | $1.00K | 0.00% |
Sold out (15)
Institutions that held Tarsus Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Cowen and Company, LLC | 522,329 | $8.94M |
| Jacobs Levy Equity Management, Inc | 86,948 | $1.49M |
| UBS Oconnor LLC | 61,000 | $1.04M |
| Two Sigma Investments, LP | 18,851 | $323.0K |
| XTX Topco Ltd | 17,865 | $306.0K |
| Martingale Asset Management L P | 14,329 | $246.0K |
| Susquehanna International Group, LLP | 14,257 | $244.0K |
| State Board of Administration of Florida Retirement System | 13,170 | $225.0K |
| Jump Financial, LLC | 12,300 | $211.0K |
| Public Employees Retirement System of Ohio | 5,500 | $94.0K |
| Acadian Asset Management LLC | 5,480 | $93.0K |
| AlphaMark Advisors, LLC | 100 | $2.00K |
| Lindbrook Capital, LLC | 106 | $2.00K |
| Parallel Advisors, LLC | 30 | $1.00K |
| Allworth Financial LP | 12 | $0 |
Not filed for Q4 2022 yet (2)
Institutions that held Tarsus Pharmaceuticals, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Jefferies Group LLC | 445,758 | $7.63M |
| American Portfolios Advisors | 39 | $668 |